Anti-malarials most effective in lupus patients genetically at risk of high levels of TNF-alpha
A study by Lopez et al. found that anti-malarial drugs significantly lower TNF-alpha levels in lupus patients with specific polymorphisms, improving treatment outcomes. Patients taking anti-malarials had better responses to therapy compared to those not on the medication.